CBD Nutraceuticals Market Analysis by Type (Capsules & Softgels, CBD Tinctures, CBD Gummies),by Distribution Channel (Online, Retail Stores, Pharmacies),and by Region - Forecast to 2029

The global CBD nutraceuticalsmarket size is estimated to be USD 5,190.1 million in 2021 and is expected to witness a CAGR of 17.14% during the forecast period. Deficiency of essential nutrients in people coupled with development of effective supplements are key drivers for global market growth. Moreover, rising awareness for plant-based nutraceuticals, growing geriatric population, commercial availability via multiple channels, favorable regulation for supplements, and increasing disposable income are other drivers propelling the market growth. However, product counterfeiting and inadequate knowledge for supplements are expected to restrain the global market growth.

Global CBD Nutraceuticals Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Type

Based on services, the market is segmented into capsules & softgels, CBD tinctures, CBD gummies, and others. In 2021, the CBD tinctures segment accountedfor the maximum revenue share due to theirnumerous benefits and wide availability, worldwide. CBD tinctures enable quick relief in stress, pain, and anxiety and are available in multiple concentrations and volume. Capsules and softgels segmentis expected to grow at the fastest CAGR during the forecast period owing to its ease of use.

By Distribution

Based on distribution, the market is categorized into online, retail stores, and pharmacies. In 2021, the retail store segment accounted for the largest revenue share due to increase in collaborationsbetweenmanufacturers andretailers &local vendors worldwide. Online segment is anticipated to grow at a significant CAGR during the forecast period due to growingtech-savvy customer base, COVID-19 outbreak that has promotedhome-based shopping, and technological advancements.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the favorable regulatory framework, increase in health-conscious consumers, and investment in R&D by manufacturers. Also,high disposable income in the U.S. and Canadais fuelling the segment growth.

Asia Pacific is projected to exhibit the fastest CAGR over the forecast period owing to the rising availability and formalization of standards for use of cannabidiol-infused products. Additionally, rising awareness for CBD nutraceuticals and regional expansion by leading players are expected to drive the segment growth in this region.

CompetitorInsights

Some of the majorcompanies in the CBD nutraceuticals market are Tikun Olam(Israel),Irwin Naturals (U.S.), OrganiGram Holdings (Canada), Charlottes Web Holdings, Inc. Wr.(U.S.), Cronos Group (Canada), CV Sciences, Inc. (U.S.), Aphria Inc. (Canada), Medical Marijuana, Inc. (U.S.), Aurora Cannabis Inc. (Canada), and Elixinol Global (Australia).The leading players have adopted strategic collaborations, mergers& acquisitions, and novel product development approaches to capture the market share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country-level along with key market trends and dynamics from 2021 to 2029. The CBD nutraceuticals market report is categorized into the following segments and subsegments:

CBD Nutraceuticals Market, By Type (Revenue, 2021-2029, USD Million)

  • Capsules & Softgels
  • CBD Tinctures
  • CBD Gummies
  • Others

CBD Nutraceuticals Market, By Distribution(Revenue, 2021-2029, USD Million)

  • Online
  • Retail Stores
  • Pharmacies
  • Others

CBD Nutraceuticals Market, By Region (Revenue, 2021-2029, USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of CBD Nutraceuticals Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: CBD Neutraceuticals Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: CBD Neutraceuticals
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: CBD Neutraceuticals Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product type
    1. CBD gummies
      1. CBD gummies Market Forecast, 2021-2029 (USD Million)
    2. CBD tincture
      1. CBD tincture Market Forecast, 2021-2029 (USD Million)
    3. Capsules & softgels
      1. Capsules & softgelsMarket Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Sales channel
    1. Online
      1. OnlineMarket Forecast, 2021-2029 (USD Million)
    2. Retail stores
      1. Retail stores Market Forecast, 2021-2029 (USD Million)
    3. Pharmacies
      1. Pharmacies Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America CBD Neutraceuticals Market
    1. North America CBD Neutraceuticals Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
      2. S. CBD NeutraceuticalsMarket
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
        2. Canada CBD NeutraceuticalsMarket
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
  1. Europe CBD Neutraceuticals Market
    1. Europe CBD Neutraceuticals Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
      2. Germany CBD NeutraceuticalsMarket
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
        2. UK CBD NeutraceuticalsMarket
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
          2. France CBD NeutraceuticalsMarket
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
            2. Spain CBD NeutraceuticalsMarket
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
              2. Italy CBD NeutraceuticalsMarket
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
                2. Rest of Europe CBD NeutraceuticalsMarket
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
  1. Asia Pacific CBD Neutraceuticals Market
    1. Asia Pacific CBD Neutraceuticals Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
      2. Japan CBD NeutraceuticalsMarket
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
        2. China CBD NeutraceuticalsMarket
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
          2. India CBD NeutraceuticalsMarket
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
            2. South Korea CBD NeutraceuticalsMarket
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia CBD NeutraceuticalsMarket
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
                2. Rest of Asia Pacific CBD NeutraceuticalsMarket
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
  1. Latin America CBD Neutraceuticals Market
    1. Latin America CBD Neutraceuticals Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
      2. Brazil CBD NeutraceuticalsMarket
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
        2. Mexico CBD NeutraceuticalsMarket
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
          2. Argentina CBD NeutraceuticalsMarket
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
            2. Rest of Latin America CBD NeutraceuticalsMarket
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
  1. MEA CBD Neutraceuticals Market
    1. MEA CBD Neutraceuticals Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
      2. GCC CBD NeutraceuticalsMarket
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
        2. South Africa CBD NeutraceuticalsMarket
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
          2. Rest of MEA CBD NeutraceuticalsMarket
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Sales channel, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2020 & 2031
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Canopy Growth Corporation (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    2. Aurora Cannabis Inc. (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    3. MedMen (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    4. Terra Tech Corp. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    5. Aphria Inc. (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    6. VIVO Cannabis Inc. (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    7. The Cronos Group (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    8. Medical Marijuana Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    9. STENOCARE (Denmark)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    10. Tikun Olam (Israel)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    11. Organigram Holdings Inc. (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    12. Cresco Labs (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    13. Indiva (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    14. Curaleaf Holding Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    15. HEXO Corp. (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product type Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Select License Type

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports